Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1Wavelength Enterprises LTD
02 1Assia Chemical Industries Ltd - Teva Tech Site
03 3Dipharma Francis Srl
04 1Glenmark Life Sciences Limited
01 5Cilostazol
02 1cilostazol
01 1France
02 1India
03 1Israel
04 3Italy
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
NDC Package Code : 58175-0379
Start Marketing Date : 2001-02-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0034
Start Marketing Date : 2017-11-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-1109
Start Marketing Date : 2005-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0632
Start Marketing Date : 2005-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46438-0633
Start Marketing Date : 2005-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-113
Start Marketing Date : 2003-10-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Cilostazol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilostazol, including repackagers and relabelers. The FDA regulates Cilostazol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilostazol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cilostazol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cilostazol supplier is an individual or a company that provides Cilostazol active pharmaceutical ingredient (API) or Cilostazol finished formulations upon request. The Cilostazol suppliers may include Cilostazol API manufacturers, exporters, distributors and traders.
click here to find a list of Cilostazol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cilostazol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cilostazol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cilostazol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cilostazol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cilostazol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cilostazol suppliers with NDC on PharmaCompass.
We have 4 companies offering Cilostazol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
